KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemed (CHE) Depreciation & Amortization - Total (2016 - 2025)

Historic Depreciation & Amortization - Total for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $13.7 million.

  • Chemed's Depreciation & Amortization - Total rose 393.25% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.1 million, marking a year-over-year increase of 272.87%. This contributed to the annual value of $52.9 million for FY2024, which is 405.89% up from last year.
  • Chemed's Depreciation & Amortization - Total amounted to $13.7 million in Q3 2025, which was up 393.25% from $13.7 million recorded in Q2 2025.
  • Chemed's Depreciation & Amortization - Total's 5-year high stood at $13.7 million during Q2 2025, with a 5-year trough of $11.7 million in Q1 2021.
  • Its 5-year average for Depreciation & Amortization - Total is $12.8 million, with a median of $12.9 million in 2023.
  • Its Depreciation & Amortization - Total has fluctuated over the past 5 years, first soared by 1675.1% in 2021, then tumbled by 659.71% in 2022.
  • Quarter analysis of 5 years shows Chemed's Depreciation & Amortization - Total stood at $11.8 million in 2021, then increased by 2.16% to $12.1 million in 2022, then rose by 7.67% to $13.0 million in 2023, then grew by 1.84% to $13.3 million in 2024, then rose by 3.02% to $13.7 million in 2025.
  • Its Depreciation & Amortization - Total was $13.7 million in Q3 2025, compared to $13.7 million in Q2 2025 and $13.4 million in Q1 2025.